Cargando…

Systematic literature review and assessment of patient-reported outcome instruments in sickle cell disease

BACKGROUND: Sickle cell disease (SCD) is a chronic condition associated with high mortality and morbidity. It is characterized by acute clinical symptoms such as painful vaso-occlusive crises, which can impair health-related quality of life (HRQL). This study was conducted to identify validated pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Sarri, Grammati, Bhor, Menaka, Abogunrin, Seye, Farmer, Caroline, Nandal, Savita, Halloway, Rashid, Revicki, Dennis A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5963009/
https://www.ncbi.nlm.nih.gov/pubmed/29784054
http://dx.doi.org/10.1186/s12955-018-0930-y
_version_ 1783324970551607296
author Sarri, Grammati
Bhor, Menaka
Abogunrin, Seye
Farmer, Caroline
Nandal, Savita
Halloway, Rashid
Revicki, Dennis A.
author_facet Sarri, Grammati
Bhor, Menaka
Abogunrin, Seye
Farmer, Caroline
Nandal, Savita
Halloway, Rashid
Revicki, Dennis A.
author_sort Sarri, Grammati
collection PubMed
description BACKGROUND: Sickle cell disease (SCD) is a chronic condition associated with high mortality and morbidity. It is characterized by acute clinical symptoms such as painful vaso-occlusive crises, which can impair health-related quality of life (HRQL). This study was conducted to identify validated patient-reported outcome (PRO) instruments for use in future trials of potential treatments for SCD. METHODS: A systematic literature review (SLR) was performed using MEDLINE and EMBASE to identify United States (US)-based studies published in English between 1997 and 2017 that reported on validated PRO instruments used in randomized controlled trials and real-world settings. The COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) checklist was used to assess the quality of PRO instruments. RESULTS: The SLR included 21 studies assessing the psychometric properties of 24 PRO instruments. Fifteen of those instruments were developed and validated for adults and 10 for children (one instrument was used in both children and young adults aged up to 21 years). Only five of the 15 adult instruments and three of the 10 pediatric instruments were developed specifically for SCD. For most instruments, there were few or no data on validation conducted in SCD development cohorts. Of the 24 PRO instruments identified, 16 had strong internal reliability (Cronbach’s α ≥0.80). There was often insufficient information to assess the content validity, construct validity, responsiveness, or test-retest reliability of the instruments identified for both child and adult populations. No validated PRO instruments measuring caregiver burden in SCD were identified. CONCLUSIONS: The evidence on the psychometric properties of PRO instruments was limited. However, the results of this SLR provide key information on such tools to help inform the design of future clinical trials for patients with SCD in the US. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12955-018-0930-y) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5963009
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-59630092018-06-25 Systematic literature review and assessment of patient-reported outcome instruments in sickle cell disease Sarri, Grammati Bhor, Menaka Abogunrin, Seye Farmer, Caroline Nandal, Savita Halloway, Rashid Revicki, Dennis A. Health Qual Life Outcomes Research BACKGROUND: Sickle cell disease (SCD) is a chronic condition associated with high mortality and morbidity. It is characterized by acute clinical symptoms such as painful vaso-occlusive crises, which can impair health-related quality of life (HRQL). This study was conducted to identify validated patient-reported outcome (PRO) instruments for use in future trials of potential treatments for SCD. METHODS: A systematic literature review (SLR) was performed using MEDLINE and EMBASE to identify United States (US)-based studies published in English between 1997 and 2017 that reported on validated PRO instruments used in randomized controlled trials and real-world settings. The COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) checklist was used to assess the quality of PRO instruments. RESULTS: The SLR included 21 studies assessing the psychometric properties of 24 PRO instruments. Fifteen of those instruments were developed and validated for adults and 10 for children (one instrument was used in both children and young adults aged up to 21 years). Only five of the 15 adult instruments and three of the 10 pediatric instruments were developed specifically for SCD. For most instruments, there were few or no data on validation conducted in SCD development cohorts. Of the 24 PRO instruments identified, 16 had strong internal reliability (Cronbach’s α ≥0.80). There was often insufficient information to assess the content validity, construct validity, responsiveness, or test-retest reliability of the instruments identified for both child and adult populations. No validated PRO instruments measuring caregiver burden in SCD were identified. CONCLUSIONS: The evidence on the psychometric properties of PRO instruments was limited. However, the results of this SLR provide key information on such tools to help inform the design of future clinical trials for patients with SCD in the US. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12955-018-0930-y) contains supplementary material, which is available to authorized users. BioMed Central 2018-05-21 /pmc/articles/PMC5963009/ /pubmed/29784054 http://dx.doi.org/10.1186/s12955-018-0930-y Text en © The Author(s). 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Sarri, Grammati
Bhor, Menaka
Abogunrin, Seye
Farmer, Caroline
Nandal, Savita
Halloway, Rashid
Revicki, Dennis A.
Systematic literature review and assessment of patient-reported outcome instruments in sickle cell disease
title Systematic literature review and assessment of patient-reported outcome instruments in sickle cell disease
title_full Systematic literature review and assessment of patient-reported outcome instruments in sickle cell disease
title_fullStr Systematic literature review and assessment of patient-reported outcome instruments in sickle cell disease
title_full_unstemmed Systematic literature review and assessment of patient-reported outcome instruments in sickle cell disease
title_short Systematic literature review and assessment of patient-reported outcome instruments in sickle cell disease
title_sort systematic literature review and assessment of patient-reported outcome instruments in sickle cell disease
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5963009/
https://www.ncbi.nlm.nih.gov/pubmed/29784054
http://dx.doi.org/10.1186/s12955-018-0930-y
work_keys_str_mv AT sarrigrammati systematicliteraturereviewandassessmentofpatientreportedoutcomeinstrumentsinsicklecelldisease
AT bhormenaka systematicliteraturereviewandassessmentofpatientreportedoutcomeinstrumentsinsicklecelldisease
AT abogunrinseye systematicliteraturereviewandassessmentofpatientreportedoutcomeinstrumentsinsicklecelldisease
AT farmercaroline systematicliteraturereviewandassessmentofpatientreportedoutcomeinstrumentsinsicklecelldisease
AT nandalsavita systematicliteraturereviewandassessmentofpatientreportedoutcomeinstrumentsinsicklecelldisease
AT hallowayrashid systematicliteraturereviewandassessmentofpatientreportedoutcomeinstrumentsinsicklecelldisease
AT revickidennisa systematicliteraturereviewandassessmentofpatientreportedoutcomeinstrumentsinsicklecelldisease